Carbimazole Related Products


Carbimazole is a medication used to reduce thyroid function and is included on the World Health Organization's List of Essential Medicines. As a pro-drug, carbimazole is converted into its active form, methimazole, after absorption. Methimazole works by inhibiting the thyroid peroxidase enzyme, preventing the iodination and coupling of tyrosine residues on thyroglobulin.


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Carbimazole, pharmacopeial and non-pharmacopeial Carbimazole impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Carbimazole impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Carbimazole-related products are thoroughly characterized. Carbimazole products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Carbimazole EP Impurity A

SZ CAT No:: SZ-C181002
CAS No: 60-56-0
Mol.F.: C4H6N2S
Mol.Wt.: 114.2
Inv. Status: In Stock
Rel. CAS No: 50476-76-1 (Na salt) ; 96592-02-8 (K salt)

Carbimazole

SZ CAT No:: SZ-C181001
CAS No: 22232-54-8
Mol.F.: C7H10N2O2S
Mol.Wt.: 186.2
Inv. Status: Custom Synthesis
Categories